Literature DB >> 29703761

Clonal T cell receptor gene rearrangements in coeliac disease: implications for diagnosing refractory coeliac disease.

Shafinaz Hussein1, Tatyana Gindin1, Stephen M Lagana1, Carolina Arguelles-Grande2, Suneeta Krishnareddy2, Bachir Alobeid1, Suzanne K Lewis2, Mahesh M Mansukhani1, Peter H R Green2, Govind Bhagat1,2.   

Abstract

AIMS: Refractory coeliac disease type II (RCDII), a rare complication of coeliac disease (CD) associated with high morbidity, requires identification of a clonal population of phenotypically aberrant intraepithelial lymphocytes (IELs) for diagnosis. However, data regarding the frequency and significance of clonal T cell receptor (TCR) gene rearrangements (TCR-GRs) in small bowel (SB) biopsies of patients without RCDII are limited.
METHODS: We analysed results of TCR-GR analyses performed on SB biopsies at our institution over a 3-year period, which were obtained from eight active CD, 172 CD on gluten-free diet (GFD), 33 RCDI, and three RCDII patients and 14 patients without CD. TCR-GR patterns were divided into clonal, polyclonal and prominent clonal peaks (PCPs) and these patterns were correlated with clinical and pathological features.
RESULTS: Clonal TCR-GR products were detected in biopsies from 67% of patients with RCDII, 17% of patients with RCDI and 6% of patients with GFD. PCPs were observed in all disease phases (range 12%-33%). There was no significant difference in the TCR-GR patterns between the non-RCDII disease categories (p=0.39). A higher frequency of surface CD3(-) IELs was noted in cases with clonal TCR-GR, but the PCP pattern did not show associations with any clinical or pathological feature. Persistence of clonal or PCP pattern on repeat biopsy was seen for up to 2 years without evidence of RCDII.
CONCLUSIONS: Clonal TCR-GRs are not infrequent in cases lacking features of RCDII, while PCPs are frequent in all disease phases. TCR-GR results should be assessed in conjunction with immunophenotypic, histological and clinical findings for appropriate diagnosis and classification of RCD. © Article author(s) (or their employer(s) unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.

Entities:  

Keywords:  coeliac disease; flow cytometry; molecular diagnostics

Mesh:

Year:  2018        PMID: 29703761     DOI: 10.1136/jclinpath-2018-205023

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  6 in total

Review 1.  Cellular Origins and Pathogenesis of Gastrointestinal NK- and T-Cell Lymphoproliferative Disorders.

Authors:  Susan Swee-Shan Hue; Siok-Bian Ng; Shi Wang; Soo-Yong Tan
Journal:  Cancers (Basel)       Date:  2022-05-18       Impact factor: 6.575

Review 2.  Refractory Celiac Disease.

Authors:  Isabel A Hujoel; Joseph A Murray
Journal:  Curr Gastroenterol Rep       Date:  2020-03-17

Review 3.  Descriptive Study of the Different Tools Used to Evaluate the Adherence to a Gluten-Free Diet in Celiac Disease Patients.

Authors:  Luis Rodrigo; Isabel Pérez-Martinez; Eugenia Lauret-Braña; Adolfo Suárez-González
Journal:  Nutrients       Date:  2018-11-16       Impact factor: 5.717

Review 4.  Celiac disease: histology-differential diagnosis-complications. A practical approach.

Authors:  Vincenzo Villanacci; Alessandro Vanoli; Giuseppe Leoncini; Giovanni Arpa; Tiziana Salviato; Luca Reggiani Bonetti; Carla Baronchelli; Luca Saragoni; Paola Parente
Journal:  Pathologica       Date:  2020-09

5.  Classification of intestinal T-cell receptor repertoires using machine learning methods can identify patients with coeliac disease regardless of dietary gluten status.

Authors:  Anna Fowler; Elizabeth J Soilleux; Andrew D Foers; M Saad Shoukat; Oliver E Welsh; Killian Donovan; Russell Petry; Shelley C Evans; Michael Eb FitzPatrick; Nadine Collins; Paul Klenerman
Journal:  J Pathol       Date:  2021-01-06       Impact factor: 9.883

6.  Adult-Onset Autoimmune Enteropathy in an European Tertiary Referral Center.

Authors:  Roy L J van Wanrooij; E Andra Neefjes-Borst; Hetty J Bontkes; Marco W J Schreurs; Anton W Langerak; Chris J J Mulder; Gerd Bouma
Journal:  Clin Transl Gastroenterol       Date:  2021-08-01       Impact factor: 4.488

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.